NAD+: What Researchers Should Know About Nicotinamide Adenine Dinucleotide

NAD+ (Nicotinamide Adenine Dinucleotide) is a long-known coenzyme that has come back into greater focus in ageing and metabolic research in recent years. The interest is based primarily on its role in energy metabolism, DNA repair, and NAD+-dependent signalling pathways. Anyone who wants to obtain NAD+ for research should know the methodological limits and the practical quality criteria.

NAD+longevity

Essential cellular coenzyme that declines with age. Powers energy metabolism in every cell, activates sirtuins (longevity genes), and supports DNA repair. A cornerstone molecule in aging and longevity research.

What is NAD+ exactly?

NAD+ is a coenzyme found in all living cells. It is involved in numerous redox and signalling processes. At its core, NAD+ fulfils two central functions:

Energy metabolism: As an electron carrier, NAD+ is central to glycolysis, the citric acid cycle, and oxidative phosphorylation. Changes in the NAD+/NADH ratio can directly influence mitochondrial ATP production.

Signalling molecule: NAD+ serves as a substrate for several enzyme families:

Sirtuins (SIRT1-7) - NAD+-dependent deacylases with roles in metabolic regulation and stress response
PARPs (Poly-ADP-Ribose Polymerases) - enzymes of the DNA damage response with relevant NAD+ consumption
CD38/CD157 - NAD+-processing ectoenzymes with functions in immune and calcium signalling networks

NAD+ as an interface of multiple systems

NAD+ is particularly relevant for researchers because it connects energy metabolism, DNA damage response, and cellular signalling pathways. This multiple role explains why changes in NAD+ homeostasis are studied in many ageing and disease models.

Why does NAD+ decline with age?

Many studies describe age-associated changes in NAD+ metabolism. However, the pattern is not uniform: human data shows rather tissue-, age-, and partly sex-specific differences than a universally valid "50% rule". Accordingly, an age-related NAD+ decline should not be presented too broadly.

CD38 and NAD+ consumption: CD38 is frequently discussed as an important driver of age-associated NAD+ consumption, particularly in connection with inflammatory processes. Preclinical studies support this role, but the quantitative dominance of CD38 over all other consumption pathways depends on the tissue and model. Bibliometric analyses can show research trends but do not demonstrate biological dominance.

Chronic inflammation and PARP activation: With increasing DNA burden, PARP activity may rise. Since PARPs consume NAD+, this axis is discussed as a plausible contributor to declining NAD+ pools.

Altered biosynthesis: In parallel, NAD+ resynthesis or recovery via salvage pathways may decrease, e.g. through changes in NAMPT-dependent processes. Here too, data differ depending on tissue and study design.

Important research framework

The literature describes NAD+ decline rather as part of a complex network of consumption, biosynthesis, inflammation, and tissue context than as a single universal mechanism.

Current research landscape

Current literature treats NAD+ primarily as a modulable metabolic hub. The field ranges from basic research to early clinical studies.

Longevity and sirtuin activation

The connection between NAD+ and sirtuin-mediated signalling pathways has been shaped by several research groups; David Sinclair's group is a visible but not the only part of the field. The basic idea remains: sirtuins require NAD+ as a substrate, so changes in NAD+ availability can have functional consequences for metabolic and stress responses.

In animal models, effects on mitochondrial function, metabolic parameters, and resilience have been repeatedly described after NAD+ elevation or after administration of precursor molecules. The translatability to humans, however, remains limited.

A review in Nature Aging by Zhang et al. from 2025 classifies strategies for NAD+ modulation into three groups: precursors such as NMN and NR, reduction of NAD+ consumption, and influencing biosynthesis. The review serves as a useful overview but does not replace an assessment of individual clinical endpoints.

More recent mouse data suggest that effects of NMN or other NAD+-related interventions may be sex-dependent. Such findings are relevant for hypothesis formation but should not be directly taken over as reliable statements for human studies.

DNA repair

NAD+ is a central substrate for PARP-mediated DNA repair processes. A low NAD+ status can therefore influence the cellular response to DNA damage. This relationship is of particular interest in ageing biology and oncology, where both the protection of healthy cells and the metabolic vulnerabilities of tumour cells are investigated.

Clinical reviews and review papers from recent years show relatively consistently that oral NAD+ precursors such as NR can increase NAD+-related metabolites in the blood. The situation is considerably less uniform for functional endpoints such as muscle strength, insulin sensitivity, or clinically relevant everyday parameters.

Mitochondrial function

NAD+ is directly involved in redox processes and also influences mitochondrial adaptive responses via NAD+-dependent enzymes. Preclinical studies report improvements in mitochondrial function and changes in oxidative stress, among other things. Which of these effects are reproducible in humans and clinically relevant remains open.

NAD+ vs. NMN vs. NR: Differences for researchers

Anyone working on NAD+ research quickly encounters three closely related molecules. The differences are relevant for research practice:

Molecule	Full name	Molecular weight	Role
NAD+	Nicotinamide Adenine Dinucleotide	663.4 g/mol	The active coenzyme itself
NMN	Nicotinamide Mononucleotide	334.2 g/mol	Direct NAD+ precursor
NR	Nicotinamide Riboside	255.2 g/mol	NAD+ precursor via additional conversion steps

NAD+ directly has the advantage for in vitro systems that no upstream conversion into the target molecule is necessary. In vivo, the questions of stability, transport, and bioavailability remain considerably more complex.

NMN is biochemically closer to the end product. In animal models, a good increase in NAD+ status has been repeatedly shown. However, how NMN reaches various tissues has not been fully clarified in all details.

The role of Slc12a8 continues to be discussed in this context. The protein was described as a possible NMN transporter, but the interpretation is controversial and should not be treated as definitively settled.

NR is converted into NAD+ via further steps. Clinically, NR is particularly relevant because it has been studied in several human trials and NAD+ metabolite blood levels could mostly be elevated with it.

Which molecule for which experimental design?

For in vitro work and direct application, NAD+ can be appropriate because cellular conversion capacity does not represent an additional variable. For many in vivo and supplementation models, NMN or NR are frequently used. The choice should be guided by the model, route of administration, and endpoint.

Quality criteria when buying NAD+

NAD+ is more sensitive than many other research substances. Accordingly, comprehensible analytical data and a clean storage and shipping chain are particularly important.

Purity testing

High chemical purity is useful for many research applications, but the specific requirement depends on the intended use. Instead of blanket thresholds, a current COA and traceable methodology details are more important.

A reliable Certificate of Analysis (COA) should make at least the following points transparent:

HPLC or UPLC purity analysis with stated result
Mass spectrometry or comparable identity verification
Water content or residual moisture, where relevant for stability and handling
Lot reference, test date, and methodology, so the document remains traceable

Additional testing such as microbiological burden, endotoxins, or sterility may be useful depending on the product category and application, but are not automatically standard for every non-sterile research-use-only substance.

EU shipping: For researchers in Europe, shipping within the EU can be logistically sensible, e.g. because of shorter transit times and less customs effort. PeptidesDirect ships from within the EU.

Storage and handling

NAD+ is considered hygroscopic and sensitive to unfavourable storage conditions. Users should therefore observe batch-specific manufacturer specifications and handle the substance as dry, cold, and light-protected as possible.

Storage notes

Lyophilised NAD+ is frequently stored deep-frozen. Before opening, it may be sensible to let the container reach ambient temperature to avoid condensation. After reconstitution, further storage should be aligned with the manufacturer's data sheet, concentration, solvent, and planned duration of use.

Practical tips for handling:

Aliquot where possible to limit repeated freeze-thaw cycles
Only keep solutions for as long as the batch stability data support
Keep light and heat exposure low during the workflow
Use suitable, clean laboratory consumables

Combination with other longevity peptides

In ageing research, NAD+ is often not studied in isolation but together with interventions that address other parts of the mitochondrial or cellular stress response.

NAD+ and SS-31: different points of attack

SS-31 (Elamipretide) is studied primarily because of its interaction with the inner mitochondrial membrane. NAD+, by contrast, primarily addresses redox and enzymatic processes. A combination is therefore conceptually interesting, even if an additive benefit cannot be automatically derived from it.

NAD+ and MOTS-c: MOTS-c is associated in research with AMPK signalling pathways and metabolic adaptation, among other things. Together with NAD+, this creates an experimental framework that addresses both redox and metabolic aspects.

NAD+ and Epitalon: Epitalon is discussed in ageing research in connection with telomere-related hypotheses, among other things. Together with NAD+, different but not completely separate ageing mechanisms can be investigated.

SS-31longevity

Mitochondria-targeted tetrapeptide (Elamipretide) that stabilizes cardiolipin and prevents ROS formation at the source.

Frequently asked questions

Order NAD+

Anyone who wants to obtain NAD+ for research should above all pay attention to traceable analytical data, a suitable shipping route, and realistic product claims. For a sensitive molecule like NAD+, transparency in the quality chain is more important than advertising superlatives.

NAD+longevity